Ratio of serum γ-GT/ALT rather than ISDR variability is predictive for initial virological response to IFN-α in chronic HCV infection

Journal of Medical Virology

Volumn 58, Issue 3, 1999, Pages 227-234

  Mihm, Sabine ^a   Monazahian, Masyar ^a   Grethe, Stefanie ^a   Fechner, Charlotte ^a   Ramadori, Giuliano ^a   Thomssen, Reiner ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

GT ALT; HCV; IFN ; Interferon sensitivity determining region

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; RECOMBINANT ALPHA2A INTERFERON;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID SEQUENCE; ARTICLE; CHRONIC HEPATITIS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; VIRUS ISOLATION; VIRUS MUTANT;

ADULT; AGED; ALANINE TRANSAMINASE; AMINO ACID SEQUENCE; ANTIVIRAL AGENTS; DATA INTERPRETATION, STATISTICAL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PREDICTIVE VALUE OF TESTS; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS); VIRAL NONSTRUCTURAL PROTEINS;

EID: 0033001639     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199907)58:3<227::AID-JMV7>3.0.CO;2-7     Document Type: Article

References (33)

1. Cammà C, Giunta M, Linea C, Pagliaro L. 1997. The effect of interferon on the liver in chronic hepatitis C: a quantitative evaluation of histology by meta-analysis. J Hepatol 26:1187-1199.
2. Chayama K, Tsubota A, Kobayashi M, Okamoto K, Hashimoto M, Miyano Y, Koike H, Kobayashi M, Koida I, Arase Y, Saitoh S, Suzuki Y, Murashima N, Ikeda K, Kumada H. 1997. Pretreatment virus load and multiple amino acid substitutions in the interferon sensitivity-determining region predict the outcome of interferon treatment in patients with chronic genotype 1b hepatitis C virus infection. Hepatology 25:745-749.
3. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. 1989. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244:359-362.
4. Davis GL. 1994. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol 21:1-3.
5. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C. 1995. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96:224-230.
6. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis virus 1b infection. N Engl J Med 334:77-81.
7. Gale MJ, Blakely CM, Kwieciszewski B, Tan S-L, Dossett M, Tang NM, Korth MJ, Polyak SJ, Gretch DR, Katze MG. 1998. Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation. Mol Cell Biol 18: 5208-5218.
8. Gale MJ, Korth MJ, Tang NM, Tan SL, Hopkins DA, Dever TE, Polyak SJ, Gretch DR, Katze MG. 1997. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217-227.
9. Greenberg HB, Pollard RB, Lutwick LI, Gregory PB, Robinson WS, Merigan TC. 1976. Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis. N Engl J Med 295:517-522.
10. Herion D, Hoofnagle JH. 1997. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same. Hepatology 25:769-771.
11. Hofgärtner WT, Polyak SJ, Sullivan DG, Carithers Jr RL, Gretch DR. 1997. Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b. J Med Virol 53:118-126.
12. Hoofnagle JH, Mullen KD, Jones DB, Rustgi V, Di Bisceglie A, Peters M, Waggoner JG, Park Y, Jones EA. 1986. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon: a preliminary report. N Engl J Med 315:1575-1578.
13. Jacobs BL, Langland JO. 1996. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 219:339-349.
14. Khorsi H, Castelain S, Wyseur A, Izopet J, Canva V, Rombout A, Capron D, Capron JP, Lunel F, Stuyver L, Duverlie G. 1997. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alpha therapy in French patients. J Hepatol 27:72-77.
15. Kolykhalov AA, Agapov EV, Blight KJ, Mihalik K, Feinstone SM, Rice CM. 1997. Transmission of hepatitis C by intrahepatic inoculation with transcribed RNA. Science 277:570-574.
16. Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, Tegtmeier GE, Bonino F, Colombo M, Lee WS, Kuo C, Berger K, Shuster JR, Overby LR, Bradley W, Houghton M. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362-364.
17. Kurosaki M, Enomoto N, Murakami T, Sakuma I, Asahina Y, Yamamoto C, Ikeda T, Tozuka S, Izumi N, Marumo F, Sato C. 1997. Analysis of genotypes and amino acid residues 2209 to 2248 of the NS5A region of hepatitis C virus in relation to the response to interferon-β therapy. Hepatology 25:750-753.
18. Malaguarnera S, Restuccia S, Trovato G, Siciliano R, Motta M, Trovato BA. 1995. Interferon-α treatment in patients with chronic hepatitis C: a meta-analytic evaluation. Clin Drug Invest 9:141-149.
19. Mihm S, Fayyazi A, Hartmann H, Ramadori G. 1997. Analysis of histopathological manifestations of chronic hepatitis C virus infection with respect to virus genotype. Hepatology 25:735-739.
20. 2a in patients with chronic hepatitis C infected by virus genotype 3a and exhibiting a low γ-GT/ALT ratio. Dig Dis Sci 41:1256-1264.
21. Nishioka K. 1994. Epidemiological studies on hepatitis C virus infection: detection, prevalence, exposure and prevention. Intervirology 37:58-67.
22. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M. 1992. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73:673-679.
23. Okamoto H, Tokita H, Sakamoto M, Horikita M, Kojima M, Iizuka H, Mishiro S. 1993. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol 74:2385-2390.
24. Pawlotsky J-M, Germanidis G, Neumann AU, Pellerin M, Frainais P-O, Dhumeaux D. 1998. Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations. J Virol 72:2795-2805.
25. Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, Koi S, Onji M, Ohta Y, Choo QL, Houghton M, Kuo G. 1990. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 87: 6547-6549.
26. Sáiz J-C, López-Labrador F-X, Ampurdanés S, Dopazo J, Forns X, Sánchez-Tapias J-M, Rodés J. 1998. The prognostic relevance of the nonstructural 5A gene interferon sensitivity determining region is different in infections with genotype 1b and 3a isolates of hepatitis C virus. J Infect Dis 177:839-847.
27. Saracco G, Rizetto M. 1995. The long-term efficacy of interferon alpha in chronic hepatitis C patients: a critical review. J Gastroenterol Hepatol 10:668-673.
28. Sherlock S. 1992. Viral hepatitis. Curr Opin Gastroenterol 8:365-373.
29. Shimotohno K. 1993. Hepatocellular carcinoma in Japan and its linkage to infection with hepatitis C virus. Semin Virol 4:305-312.
30. Squadrito G, Leone F, Sartori M, Nalpas B, Berthelot P, Raimondo G, Pol S, Bréchot C. 1997. Mutations in the nonstructural 5A region of hepatitis C virus and response of chronic hepatitis C to interferon alpha. Gastroenterology 113:567-572.
31. Tine F, Magrin S, Craxi A, Pagliaro I. 1991. Interferon in non-A, non-B hepatitis: a meta-analysis of randomised clinical trials. J Hepatol 13:192-199.
32. Wong DKH, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcote J. 1993. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis. Ann Intern Med 119:312-323.
33. Zeuzem S, Lee JH, Roth WK. 1997. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alpha. Hepatology 25:740-744.